Advantages of bridging to durable left ventricular assist device with the Impella 5.0

Manish K. Patel
The mainstay therapy for patients in critical cardiogenic shock (CS) is temporary mechanical circulatory support. Although there is a trend toward use of durable left ventricular assist devices (LVAD) in patients that are less ill, we present our experience with using the Impella 5.0 (Abiomed) to illustrate the potential benefits of supporting patients with critical CS before durable LVAD implantation. Since 2012, our use of the Impella has increased from 5 to 38 per year....
This data repository is not currently reporting usage information. For information on how your repository can submit usage information, please see our documentation.